Jane Street Group, LLC Bolt Biotherapeutics, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 41,868 shares of BOLT stock, worth $19,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,868
Previous 28,102
48.99%
Holding current value
$19,677
Previous $18,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BOLT
# of Institutions
37Shares Held
18.3MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$1.79 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$1.66 Million0.38% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.29 Million0.12% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$888,9890.96% of portfolio
-
Nan Fung Group Holdings LTD Central, K31.17MShares$548,4670.63% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $17.7M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...